Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)

Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)

BackgroundImmune-Oncology (IO) improves Overall Survival (OS) in metastatic Renal Cell Carcinoma (mRCC). The prognostic impact of previous Cytoreductive Nephrectomy (CN) and radical nephrectomy (RN), with curative intent, in patients treated with IO is not well defined. The aim of our paper is to ev...

Full description

Bibliographic Details
Main Authors: Marco Stellato, Daniele Santini, Elena Verzoni, Ugo De Giorgi, Francesco Pantano, Chiara Casadei, Giuseppe Fornarini, Marco Maruzzo, Andrea Sbrana, Giuseppe Di Lorenzo, Mariella Soraru, Emanuele Naglieri, Sebastiano Buti, Rocco De Vivo, Andrea Napolitano, Francesca Vignani, Claudia Mucciarini, Francesco Grillone, Giandomenico Roviello, Marilena Di Napoli, Giuseppe Procopio
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
nephrectomy
immune-oncology
metastatic renal cell carcinoma
immunotherapy
nivolumab
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.682449/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.682449/full

Similar Items